chlodantane · sovietrx dossier

identity

formula

C₁₇H₂₀ClNO

label chlodantane line actoprotector school adamantane programme

pubchem CID 959689

N-(2-adamantyl)-N-(p-chlorobenzoyl)amine. Structural neighbour of bromantane. No local structure PNG in assets.

Formula text only; no molecule drawing. Archive identity plate.

Key takeaways

Chlodantane is an adamantane actoprotector scaffold neighbour of bromantane: N-(2-adamantyl)-N-(p-chlorobenzoyl)amine (C₁₇H₂₀ClNO; PubChem CID 959689).
Mapped dedicated work is sparse: a rat pharmacokinetic study (Khoronko 2005) and later structural-analogue neighbourhood papers. Most actoprotector density sits on bromantane.
This page is a thin archive sibling of the featured bromantane dossier.

What it is

Chlodantane sits in the adamantane actoprotector line as a chlorobenzoyl analogue of bromantane. Corpus text frames it as a single-dose adaptogen of the oestrogen-activity type in pre-clinical writing.

Pharmacokinetic writing distinguishes a more uniform two-compartment tissue profile than bromantane's three-compartment pattern.

We keep it because the adamantane shelf needs the thin analogues visible beside the featured compounds.

What the literature describes

Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.

Pharmacokinetics versus bromantane

Synthesis summarises Khoronko 2005 rat pharmacokinetics: two-compartment tissue distribution with fast equilibration across brain, liver, spleen, testes, kidneys, lungs and skeletal muscle; only fat shows slow equilibration. Bromantane is described with three compartments in the same school comparison.

Actoprotector class neighbourhood

Class reviews and later camphor-derived analogue work place chlodantane in the actoprotector / adaptogen neighbourhood without making it the focus compound. PubMed retrieval for this entry is noisy with bemitil, bromantane and unrelated meteoadaptogen rows; the curated list below keeps only rows that are at least class-adjacent in title language.

PubMed · PubMed

Research trail

Dedicated chlodantane focus papers are rare. The usable trail is pharmacokinetic comparison to bromantane plus actoprotector class reviews.

No Russian CyberLeninka chip set was attached to this dossier in the prior map.

Open limits

Why the p-chlorobenzoyl substitution collapses the tissue tiers relative to bromantane remains thinly argued in open text.
Head-to-head swimming or endurance assays versus bromantane are not in our mapped set.
Many PubMed retrieval rows are sibling-compound bleed and are not treated as chlodantane evidence.

Also on PubMed

2009 [Meteoadaptogenic properties of antihypoxic drugs]. PubMed
2000 [Experimental study of combined effect of actoprotectors and radioprotectors in radiation injury]. PubMed
2000 [Effect of the long term administration of bromantan on the reproductive function in rats]. PubMed
1998 [Changes in the serum albumin system during toxic syndrome and their pharmacologic correction]. PubMed

4 curated · noisy sibling-compound and off-focus rows trimmed (bemithyl cirrhosis, community pneumonia algorithm, peptide meteoadaptogen volunteers, 3-oxypyridine performance)

Still open

Is there a modern dedicated pharmacology paper with chlodantane as the primary analyte?
How should camphor-derived aniline analogues be linked without merging scaffolds?
Does any open head-to-head endurance assay versus bromantane exist outside closed military series?

Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.

← back to the archive